InSeal Medical Receives CE Mark for Vascular Closure Device

Knobbe Martens
Contact

InSeal Medical recently announced that it has received CE Mark approval for its InClosure large bore vascular closure device (VCD).  The InSeal VCD provides an internal biodegradable membrane for sealing large cuts in blood vessels.  The figures below show InSeal’s InClosure VCD, before (left) and after (right) biodegradation.

InSeal's InClosure VCD, before and after biodegredation. http://www.insealmedical.com/technology.html

According to PRNewswire, the need for such a device is, at least partially, driven by the increased prevalence of transcatheter heart valve procedures, which involve the delivery of relatively large medical device through a patient’s blood vessels.  While superior in some respects to open-heart surgical alternatives, these transcatheter procedures still require making a large puncture in a blood vessel in order to introduce the medical device.  The InClosure device is aimed at addressing these punctures.

InSeal Medical, Ltd. is a subsidiary of E-Pacing, Inc., and is based in Caesarea, Israel.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Knobbe Martens | Attorney Advertising

Written by:

Knobbe Martens
Contact
more
less

Knobbe Martens on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide